Frank Rimerman Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Frank Rimerman Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.42M	Buy	174,383 +113,367	+186%	+$1.58M	0.16%	106
2025 Q4	$857K	Sell	61,016 -47,022	-44%	-$660K	0.05%	264
2025 Q3	$1.51M	Buy	108,038 +13,356	+14%	+$192K	0.1%	156
2025 Q2	$1.42M	Buy	94,682 +39,719	+72%	+$567K	0.1%	159
2025 Q1	$725K	Sell	54,963 -550	-1%	-$7.59K	0.06%	245
2024 Q4	$877K	Sell	55,513 -117,852	-68%	-$1.77M	0.06%	214
2024 Q3	$2.75M	Buy	173,365 +580	+0.3%	+$9.33K	0.2%	84
2024 Q2	$2.63M	Buy	+172,785	New	+$2.48M	0.19%	89

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Frank Rimerman Advisors's RDY Position: Q1 2026 in Review

Frank Rimerman Advisors increased its Dr. Reddy's Laboratories (RDY) stake by 186% in Q1 2026, buying an estimated $1.58M and bringing the position to 174,383 shares worth $2.42M. The position accounts for 0.16% of the portfolio, ranked #106.

Frank Rimerman Advisors first reported a position in RDY in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.75M in Q3 2024. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

Frank Rimerman Advisors held 174,383 shares of Dr. Reddy's Laboratories worth $2.42M as of Q1 2026.
Frank Rimerman Advisors bought 113,367 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $1.58M.
Dr. Reddy's Laboratories made up 0.16% of Frank Rimerman Advisors's portfolio in Q1 2026, its #106 holding.
Frank Rimerman Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2024 and has held it in 8 quarters since.
Frank Rimerman Advisors's Dr. Reddy's Laboratories position peaked at $2.75M in Q3 2024.
247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.